Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical
procedures and improves survival rates in obstetric and trauma patients with severe …

Trauma-induced pulmonary thromboembolism is the second leading cause of death in
severe trauma patients. Primary fibrinolytic hyperactivity combined with hemorrhage and …

Introduction Trauma patients have an increased risk of deep vein thrombosis (DVT). Early
identification of patients with a high risk of DVT after trauma is crucial for thromboembolism …

Trauma-induced coagulopathy (TIC) is caused by post-traumatic tissue injury and manifests
as hypercoagulability that leads to thromboembolism or hypocoagulability that leads to …

Introduction Tranexamic acid (TXA) is a standard component of Tactical Combat Casualty
Care. Recent retrospective studies have shown that TXA use is associated with a higher rate …

Although the reports on the use of tranexamic acid (TXA) date back to the early 1960s, TXA
experienced a renaissance after publication of the report of the Clinical Randomisation of an …

Objectives: In combat casualty care, tranexamic acid (TXA) is administered as part of initial
resuscitation effort; however, conflicting data exist as to whether TXA contributes to …

BACKGROUND Combat casualties receiving damage control laparotomy at forward
deployed, resource-constrained US Military Role 2 surgical units (R2) require multiple …

Background Deep vein thrombosis (DVT) is a common complication in orthopedic patients.
Previous studies have focused on major orthopedic surgery. There are few studies with …

Background Patients with pelvic and/or acetabular fractures are at high risk of developing
thromboembolic (TE) complications. In our study we investigate TE complications and the …